SlideShare a Scribd company logo
1 of 80
Download to read offline
Debre Berhan University
Health Science College
Pharmacy Department
Pharmaceutics Unit
Aychew M. (B.Pharm, MSc Candidate)
2014E.C
Radiopharmaceuticals
Integrated Physical Pharmacy and
Pharmaceutics II (Phar 3121)
Chapter objective
➢After completion of this chapter, you will be
able to:
✓Compare and contrast the three principal types of
radioactive decay
✓Discuss the use of radiopharmaceuticals in
diagnostics and therapeutics.
✓Discuss preparation of radiopharmaceuticals
By: Aychew M. IPP II(Phar3121) 2014EC 2
Chapter objective…
✓Enumerate the ideal properties of
radiopharmaceuticals
✓Describe storage and disposal of
radiopharmaceuticals
By: Aychew M. IPP II(Phar3121) 2014EC 3
Introduction
➢Radiopharmaceutical is a radioactive
pharmaceutical agent that is used for diagnostic or
therapeutic procedures
✓ The diagnostic side is well established, while the
therapeutic side of nuclear medicine is evolving
➢Radiation is an inherent characteristic of all
radiopharmaceuticals, and patients always receive
an unavoidable radiation dose
By: Aychew M. IPP II(Phar3121) 2014EC 4
Introduction…
➢A radiopharmaceutical can be
✓As simple as a radioactive element such as
133Xe,
✓A simple salt such as 131I-NaI, or
✓A labeled compound such as 131I-iodinated
proteins and 99mTc-labeled compounds.
(Technetium-99m)
By: Aychew M. IPP II(Phar3121) 2014EC 5
Introduction…
➢A radiopharmaceutical has two components
✓ Radionuclide
❖ Provides the desired radiation characteristics
✓ Pharmaceutical
❖ A chemical compound with structural or
chemical properties that determine the in vivo
distribution and physiological behavior of the
radiopharmaceutical
✓ Other additives
By: Aychew M. IPP II(Phar3121) 2014EC 6
Introduction…
➢A suitable radionuclide is tagged onto the chosen
pharmaceutical such that after administration of
the radiopharmaceutical, radiations emitted from
it are detected by a radiation detector
✓Thus, the morphologic structure or the
physiologic function of the organ can be
assessed
By: Aychew M. IPP II(Phar3121) 2014EC 7
Introduction…
➢The usefulness of a radiopharmaceutical is
dictated by the characteristics of these two
components which are radionuclide and
pharmaceutical
By: Aychew M. IPP II(Phar3121) 2014EC 8
Radionuclide
➢ Radionuclides are unstable nuclei that are
stabilized upon radioactive decay.
➢Approximately 3000 nuclides have been
discovered so far; most of these are unstable, but
only about 30 of these are routinely used in
nuclear medicine.
By: Aychew M. IPP II(Phar3121) 2014EC 9
Radionuclide…
➢The nucleus of an atom is composed of protons
and neutrons, collectively called nucleons.
✓The number of protons in a nucleus is called the
atomic number of the atom, denoted by Z.
✓The number of neutrons is denoted by N.
➢The total number of nucleons in a nucleus is
referred to as the mass number, denoted by A.
Thus, A is equal to Z + N.
By: Aychew M. IPP II(Phar3121) 2014EC 10
Radionuclide…
➢The ratio N/Z is an approximate index of the
stability of a nuclide.
✓This ratio equals 1 in the stable nuclei with a
low atomic number, such as 12
6C, 16
8O, and 14
7N
✓The ratio increases with the increasing atomic
number of the nucleus.
✓For example, it is 1.40 for 127
53I and 1.54 for
208
82Pb.
By: Aychew M. IPP II(Phar3121) 2014EC 11
Radionuclide…
➢Nuclei with N/Z different from the stable nuclei
are unstable and decay by emitting different types
of ionizing radiation:
✓Alpha (α)
✓Beta minus (β-)
✓Positron (β+) and
✓Gamma (γ) radiation.
By: Aychew M. IPP II(Phar3121) 2014EC 12
Decay of Radionuclide
➢If the daughter nucleus is stable, this
spontaneous transformation ends
✓If the daughter is unstable, the process
continues until a stable nuclide is reached
➢Diagnostic radiopharmaceuticals should decay
by gamma emission or positron emission
By: Aychew M. IPP II(Phar3121) 2014EC 13
Decay of Radionuclide…
➢Therapeutic radiopharmaceuticals should decay
by particulate decay (alpha or beta minus) since
the intended effect is radiation damage to specific
cells
By: Aychew M. IPP II(Phar3121) 2014EC 14
Decay of Radionuclide…
Alpha () decay
➢Alpha () decay is characterized by the emission
of an alpha particle from the nucleus.
➢ particle is a helium ion containing two
protons and two neutrons bound together in the
nucleus. 2
4
2
4
A
2
Z
A
Z He
Y
X +
−
− +
→
By: Aychew M. IPP II(Phar3121) 2014EC 15
Decay of Radionuclide…
➢The  particles are mono-energetic, and their
range in matter is very short (on the order of 10-6
cm) due to their mass, thus leaving much of its
energy on a very small area (only a few cell
diameters)
➢Used only for therapeutic purposes
➢Their clinical use is very limited, and they are
mainly used for research purposes
By: Aychew M. IPP II(Phar3121) 2014EC 16
Beta-Minus (Negatron) Decay
➢Beta-minus (-) decay characteristically occurs
with radionuclides that have an excess number of
neutrons (‘‘neutron rich’’) compared with the
number of protons
i.e., has a higher N/Z ratio compared to the
stable nucleus
In - decay, a neutron (n) decays into a proton
(p) and a - particle
By: Aychew M. IPP II(Phar3121) 2014EC 17
Beta-Minus (Negatron) Decay…
➢After - decay, the atomic number of the daughter
nuclide is one more than that of the parent nuclide;
however, the mass number remains the same for
both nuclides
✓ An antineutrino ( ) is an entity almost without
mass and charge and is primarily needed to
conserve energy in the decay

β
Y
X -
A
1
Z
A
Z +
+
→ +

By: Aychew M. IPP II(Phar3121) 2014EC 18
Beta-Minus (Negatron) Decay…
➢The - particle is emitted with variable energy
from zero up to the decay energy.
✓The decay or transition energy is the difference
in energy between the parent and daughter
nuclides.
✓An antineutrino carries away the difference
between the - particle energy and the decay
energy.
By: Aychew M. IPP II(Phar3121) 2014EC 19
Decay of Radionuclide…
By: Aychew M. IPP II(Phar3121) 2014EC 20
Beta-Minus (Negatron) Decay…
➢Beta emitters represent different energy levels,
and have different range in matter (40-100μm)
depending on their energy.
➢Beta particles are not as destructive as alpha
particles
✓However, Beta emitting radionuclides are used
in radiopharmaceuticals mainly for therapeutic
purposes
By: Aychew M. IPP II(Phar3121) 2014EC 21
Decay of Radionuclide…
Positron or β+ Decay
➢Nuclei that are ‘‘neutron deficient’’ or ‘‘proton
rich’’ (i.e., have an N/Z ratio less than that of the
stable nuclei) can decay by β+-particle emission
accompanied by the emission of a neutrino (V),
which is an opposite entity of the antineutrino.
By: Aychew M. IPP II(Phar3121) 2014EC 22
Positron or β+ Decay…
➢In β+ decay, a proton transforms into a neutron by
emitting a β+ -particle
✓The daughter nuclide has an atomic number that
is 1 less than that of the parent
➢Since a β+ particle can be emitted with energy
between zero and decay energy, the neutrino
carries away the difference between decay energy
and β+ energy. 23
Positron or β+ Decay…

β
Y
X A
1
-
Z
A
Z +
+
→ +
By: Aychew M. IPP II(Phar3121) 2014EC 24
Decay of Radionuclide….
Gamma radiation
➢A nucleus can remain in several excited energy
states above the ground state
✓All these excited states are referred to as
isomeric states and decay to the ground state
✓The decay of an upper excited state to a lower
excited state is called the isomeric transition
By: Aychew M. IPP II(Phar3121) 2014EC 25
Gamma radiation…
➢In isomeric transition, the energy difference
between the energy states may appear as gamma
(γ) rays.
✓Gamma radiation is characterized as
electromagnetic radiation
✓When used in diagnostic radiopharmaceuticals,
gamma rays are powerful enough to be detected
outside the body of the patient
By: Aychew M. IPP II(Phar3121) 2014EC 26
Activity of Radionuclide
➢The activity of radioactive material may be
calculated by a decay equation that allows the
clinician to predict the activity at any time
➢The specific decay equation:
Where: Ao is the initial activity,
✓ Ae is the specific activity at time t,
✓ λ is the decay constant calculated as
ln2/half life, and t is time
By: Aychew M. IPP II(Phar3121) 2014EC 27
Activity of radioactive…
➢The fundamental unit of radioactivity is the curie
(Ci)
✓Defined as 3.700 × 1010 nuclear
transformations per second or disintegrations
per second (dps)
➢ Another unit of activity is the becquerel (Bq).
✓The becquerel is equivalent to 2.703 × 10−11 Ci
By: Aychew M. IPP II(Phar3121) 2014EC 28
Activity of radioactive…
Example
➢If a doctor is prescribed a 15 mCi dose of
99mTc to the patient how much is it in Bq
By: Aychew M. IPP II(Phar3121) 2014EC 29
Activity of radioactive…
➢The amount of radiation absorbed by body tissue
in which a radioactive substance resides is called
the radiation dose.
✓The Gray (Gy) is the international unit of
absorbed dose, equal to 1 joule of energy
absorbed by 1 kg of tissue
➢Radiopharmaceutical doses are dispensed to
patients in units of activity, typically mCi or μCi.
By: Aychew M. IPP II(Phar3121) 2014EC 30
Production of Radionuclide
➢All radionuclides commonly administered to
patients in nuclear medicine are artificially
produced
➢Most are produced by:
✓Cyclotrons
✓Nuclear reactors
✓Radionuclide generators
By: Aychew M. IPP II(Phar3121) 2014EC 31
Production of Radionuclide…
Cyclotron-Produced Radionuclides
➢Cyclotrons produce radionuclides by bombarding
stable nuclei (target elements) with high-energy
charged particles such as protons, deutérons,
and α particules
➢When targets of stable elements are irradiated
nuclear reactions take place.
By: Aychew M. IPP II(Phar3121) 2014EC 32
Cyclotron-Produced Radionuclides…
➢In a nuclear reaction, the incident particle may
leave the nucleus after the interaction, leaving
some of its energy in it, or it may be completely
absorbed by the nucleus, depending on the
energy of the incident particle.
By: Aychew M. IPP II(Phar3121) 2014EC 33
Cyclotron-Produced Radionuclides…
➢Depending on the energy deposited by the
incident particle, a number of nucleons are
emitted randomly from the irradiated target
nucleus, leading to the formation of different
nuclides.
By: Aychew M. IPP II(Phar3121) 2014EC 34
Cyclotron-Produced Radionuclides…
➢Cyclotron-produced radionuclides are usually
neutron deficient and therefore decay by β+
emission
Example
➢ Iodine-123 can be produced by several nuclear
reactions in cyclotron such as
✓ 121Sb(α, 2n) 123I 123Te (p, n) 123I
✓ 122Te (d, n)123I 124Te(p, 2n) 123I.
By: Aychew M. IPP II(Phar3121) 2014EC 35
Cyclotron-Produced Radionuclides…
➢Gallium-67 can also be produced by several
nuclear reactions
✓66Zn(d, n)67Ga,
✓68Zn(p, 2n) 67Ga, and
✓64Zn(α, Þ) 67Ga.
By: Aychew M. IPP II(Phar3121) 2014EC 36
Production of Radionuclide…
Reactor-Produced Radionuclides
➢A nuclear reactor is constructed with fuel rods
made of fissile materials such as enriched 235U &
239Pu
➢When a target element is inserted in the reactor
core, a thermal neutron will interact with the
target nucleus to produce various radionuclides.
By: Aychew M. IPP II(Phar3121) 2014EC 37
Reactor-Produced Radionuclides…
➢In the reactor, two types of interaction with
neutrons are of considerable importance in the
production of various useful radionuclides:
✓Fission of heavy elements
✓Neutron capture reaction
By: Aychew M. IPP II(Phar3121) 2014EC 38
Reactor-Produced Radionuclides…
Fission Reaction
➢ Fission is defined as the breakup of a heavy
nucleus into two fragments of approximately
equal mass, accompanied by the emission of
two to three neutrons with mean energies of
about 1.5 MeV.
By: Aychew M. IPP II(Phar3121) 2014EC 39
Reactor-Produced Radionuclides…
➢When a target of heavy elements is inserted in the
reactor core, heavy nuclei absorb thermal
neutrons and undergo fission.
➢Fissionable heavy elements are 235U, 239Pu, 237Np,
232Th.
By: Aychew M. IPP II(Phar3121) 2014EC 40
Reactor-Produced Radionuclides…
➢Many clinically useful radionuclides such as 131I,
99Mo, 133Xe, and 137Cs are produced by fission of
235U.
By: Aychew M. IPP II(Phar3121) 2014EC 41
Reactor-Produced Radionuclides…
➢Nuclides produced by fission may range in
atomic number from about 28 to nearly 65
➢These isotopes of different elements are separated
by appropriate chemical procedures that involve:
✓ Precipitation
✓ Solvent extraction
✓ Ion exchange chromatography
➢The fission products are usually neutron-rich and
decay by - particle emission
By: Aychew M. IPP II(Phar3121) 2014EC 42
Reactor-Produced Radionuclides…
Neutron Capture Reaction
➢The target nucleus captures one thermal neutron
and emits gamma (γ) rays to produce an isotope
of the same element
✓The target and the product nuclei belong to the
same element
By: Aychew M. IPP II(Phar3121) 2014EC 43
Neutron Capture Reaction…
➢Some examples of neutron capture reactions are
✓98Mo(n, γ ) 99Mo
✓196Hg(n, γ) 197Hg
✓50Cr (n, γ) 51Cr
By: Aychew M. IPP II(Phar3121) 2014EC 44
Production of Radionuclide…
Radionuclide Generators
➢Since cyclotrons and reactors are expensive,
these facilities are limited and supply
radionuclide to remote facilities that do not
possess such equipment.
By: Aychew M. IPP II(Phar3121) 2014EC 45
Radionuclide Generators…
➢Very short-lived radionuclides are available only
in the institutions that have the cyclotron or
reactor facilities; they cannot be supplied to
remote institutions or hospitals because they
decay rapidly.
By: Aychew M. IPP II(Phar3121) 2014EC 46
Radionuclide Generators…
➢For remote facilities, however, there is a
secondary source of radionuclides, particularly
short-lived ones, which is called a radionuclide
generator
By: Aychew M. IPP II(Phar3121) 2014EC 47
Radionuclide Generators…
Principles of a Generator
➢A generator is constructed on the principle of the
decay-growth relationship between a long-lived
parent radionuclide and its short-lived daughter
radionuclide.
➢In a generator, basically a long-lived parent nuclide
is allowed to decay to its short-lived daughter
nuclide, and the latter is then chemically separated.
By: Aychew M. IPP II(Phar3121) 2014EC 48
Radionuclide Generators…
➢The importance of radionuclide generators lies in
the fact that they are easily transportable and
serve as sources of short-lived radionuclides in
institutions far from the site of a cyclotron or
reactor facility.
By: Aychew M. IPP II(Phar3121) 2014EC 49
Radionuclide Generators…
➢An ideal radionuclide generator should be
✓ Simple
✓ Convenient
✓ Rapid to use
✓ Give a high yield of the daughter nuclide
repeatedly and reproducibly
✓ Properly shielded to minimize radiation
exposure
✓ Strong and compact for shipping
By: Aychew M. IPP II(Phar3121) 2014EC 50
Radionuclide Generators…
➢Generator systems important in nuclear medicine:
✓99Mo – 99mTc
✓113Sn – 113mIn
✓82Sr – 82Rb
✓68Ge – 68Ga
By: Aychew M. IPP II(Phar3121) 2014EC 51
99Mo–99mTc Generator system
➢The parent radionuclide 99Mo has a half-life of 66
hr and decays to the metastable state 99mTc
➢The daughter radionuclide 99mTc has a half-life of
6 hr and decays to 99Tc (stable one) by the
isomeric transition of 140 keV (emit gamma-ray)
✓Nearly ideal for the current generation of
imaging devices in nuclear medicine.
By: Aychew M. IPP II(Phar3121) 2014EC 52
Ideal properties of radiopharmaceutical
1. Easy Availability
➢ Should be inexpensive, and readily available in
any nuclear medicine facility.
2. Short Effective Half-Life
➢ A radionuclide decays with a definite half-life,
which is called the physical half-life (the time
during which an initial activity of a
radionuclide is reduced to one half- Tp) and
By: Aychew M. IPP II(Phar3121) 2014EC 53
Ideal properties of radiopharmaceutical…
➢ It disappears from the body with a certain
biologic half-life (the time needed for half of the
radiopharmaceutical to disappear from the
biologic system - Tb).
➢ In any biologic system, the loss of a
radiopharmaceutical is due to both the physical
decay of the radionuclide and the biologic
elimination of the radiopharmaceutical
By: Aychew M. IPP II(Phar3121) 2014EC 54
Ideal properties…
✓ Therefore the effective half-life can be given as:
✓ Radiopharmaceuticals should have a relatively
short effective half-life, which should not be
longer than the time necessary to complete the
study in question.
By: Aychew M. IPP II(Phar3121) 2014EC 55
Ideal properties…
Example
➢The physical half-life of 111In is 67 hr and the
biologic half-life of 111In-DTPA used for
measurement of the glomerular filtration rate is
1.5 hr. What is the effective half-life of 111In-
DTPA?
By: Aychew M. IPP II(Phar3121) 2014EC 56
3. Appropriate radiation
oParticle Emission
➢Radionuclides decaying by α- and β-particle
emission should not be used as the label in
diagnostic radiopharmaceuticals.
➢These particles cause more radiation damage to
the tissue than do γ rays
➢α and β emitters are useful for therapy, because
of the effective radiation damage to abnormal
cells.
By: Aychew M. IPP II(Phar3121) 2014EC 57
Ideal properties…
oGamma (γ)emitter
For diagnostic studies the radionuclide must
emit a γ radiation with an energy preferably
between 30 and 300 keV.
Below 30 keV, γ rays are absorbed by tissue
and are not detected by the detector
By: Aychew M. IPP II(Phar3121) 2014EC 58
Gamma (γ)emitter …
Above 300 keV, the gamma ray penetrate the
detector of the imaging device without being
stopped and hence recorded.
By: Aychew M. IPP II(Phar3121) 2014EC 59
By: Aychew M. IPP II(Phar3121) 2014EC 60
Ideal properties…
4. High Target-to-Non-target Activity Ratio
For diagnostic study, it is desirable that the
radiopharmaceutical be localized preferentially
in the organ under study since the activity from
non-target areas can obscure the structural
details of the picture of the target organ.
By: Aychew M. IPP II(Phar3121) 2014EC 61
High Target-to-Non-target Activity Ratio…
➢A low target-to-non-target ratio may result in
inadequate treatment of the primary disease and
delivery of a potentially lethal radiation dose to
bone marrow or other radiosensitive tissues
By: Aychew M. IPP II(Phar3121) 2014EC 62
Ideal properties…
5. Low dose rate to both patient and personnel
6. Non-toxicity of radiopharmaceuticals
They must be non-toxic in nature, sterile and
pyrogenic-free.
7. Chemical Reactivity
Should react with variety of substrates for
radiolabeling reactions
By: Aychew M. IPP II(Phar3121) 2014EC 63
Ideal properties…
8. Chemical stability during use
Must be stable both pre- and post-reconstitution
9. Ease of preparation and appropriate quality
control
Several steps and a complex variety of
equipment should not be required.
By: Aychew M. IPP II(Phar3121) 2014EC 64
Ideal properties…
Quality control procedures should be available
to check each batch of the radiopharmaceutical
reconstituted in the working laboratory.
By: Aychew M. IPP II(Phar3121) 2014EC 65
Storage of radiopharmaceuticals
Should be properly stored so that they are not
degraded by light or temperature.
For example
99mTc-labeled macro aggregated albumin
should be stored at 2 to 4oC to prevent any
bacterial growth and denaturation of proteins,
99mTc-sulfur colloid can be stored at room
temperature without any adverse effect.
By: Aychew M. IPP II(Phar3121) 2014EC 66
Storage…
Since radiation exposure is a serious problem in
the nuclear pharmacy, the vials or syringes
containing radiopharmaceuticals must be stored
in a shielded area.
Various high atomic number materials that absorb
radiation can be used to provide radiation
protection.
By: Aychew M. IPP II(Phar3121) 2014EC 67
Storage…
Since the ranges of α and β particles are short in
the matter, the containers themselves act as
shields for these radiations.
γ radiations are highly penetrating, and therefore
highly absorbing material must be used for
shielding of γ -emitting sources.
➢For economic reasons, lead is most commonly
used for this purpose.
By: Aychew M. IPP II(Phar3121) 2014EC 68
Lead barrier shield, behind which all formulations
and manipulations of radioactive materials are
carried out.
By: Aychew M. IPP II(Phar3121) 2014EC 69
Storage…
Lead-shield syringe holder for transporting the
syringes containing radioactive material.
By: Aychew M. IPP II(Phar3121) 2014EC 70
Radioactive Waste Disposal
Radioactive waste generated in nuclear medicine
or pharmacy (e.g., syringes, needles, vials
containing residual activities, liquid waste, gas,
and contaminated papers, tissues, and liners) is
disposed of by the following methods:
Decay-in-storage
Release into a sewerage system
By: Aychew M. IPP II(Phar3121) 2014EC 71
Radioactive Waste Disposal…
Transfer to an authorized recipient
Other disposal methods (e.g., incineration and
atmospheric release of radioactive gases).
By: Aychew M. IPP II(Phar3121) 2014EC 72
Radioactive Waste Disposal…
Decay-in-storage
Radionuclides with half-lives less than 120 days
usually are disposed of by this method.
By: Aychew M. IPP II(Phar3121) 2014EC 73
Decay-in-storage…
The waste is allowed to decay for a period of
time and then surveyed. If the radioactivity of
the waste cannot be distinguished from the
background, it can be disposed of in the normal
trash after the removal of all radiation labels.
By: Aychew M. IPP II(Phar3121) 2014EC 74
Decay-in-storage…
Most appropriate for short-lived radionuclides
such as 99mTc, 123I, 201Tl, 111In, and 67Ga,
By: Aychew M. IPP II(Phar3121) 2014EC 75
Radioactive Waste Disposal…
Release into a Sewerage System
Radioactive waste disposal into a sewerage
system is permitted provided the radioactive
material is soluble (or dispersible biological
material) in water.
Disposal depends on the flow rate of water but is
limited to 1 Ci (37 GBq) of 14C, 5 Ci (185 GBq)
of 3H, and 1 Ci (37 GBq) for all other
radionuclides annually. By: Aychew M. IPP II(Phar3121) 2014EC 76
Radioactive Waste Disposal…
Transfer to an Authorized Recipient
➢A transfer to an authorized recipient method is
adopted for long-lived radionuclides
➢Usually involves the transfer of radioactive waste
to authorized commercial firms that bury or
incinerate it at approved sites or facilities.
By: Aychew M. IPP II(Phar3121) 2014EC 77
By: Aychew M. IPP II(Phar3121) 2014EC 78
By: Aychew M. IPP II(Phar3121) 2014EC 79
Radiopharmaciutics......................................

More Related Content

Similar to Radiopharmaciutics......................................

Nuclear Medicine.pdf
Nuclear Medicine.pdfNuclear Medicine.pdf
Nuclear Medicine.pdfASPhoenix
 
Nuclear Medicine.pdf
Nuclear Medicine.pdfNuclear Medicine.pdf
Nuclear Medicine.pdfASPhoenix
 
COMPARISION BETWEEN 1 H & 13 C NMR
COMPARISION  BETWEEN  1 H  & 13 C NMRCOMPARISION  BETWEEN  1 H  & 13 C NMR
COMPARISION BETWEEN 1 H & 13 C NMRRaju Sanghvi
 
COMPARISION BETWEEN 1 H & 13 C NMR
COMPARISION  BETWEEN  1 H  & 13 C NMRCOMPARISION  BETWEEN  1 H  & 13 C NMR
COMPARISION BETWEEN 1 H & 13 C NMRRaju Sanghvi
 
تشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسي
تشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسيتشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسي
تشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسيssuserf14e50
 
تشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسي
تشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسيتشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسي
تشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسيssuserf14e50
 
25.0 Nuclear Physics Sem 3.pptx
25.0 Nuclear Physics Sem 3.pptx25.0 Nuclear Physics Sem 3.pptx
25.0 Nuclear Physics Sem 3.pptxssuser955fb81
 
25.0 Nuclear Physics Sem 3.pptx
25.0 Nuclear Physics Sem 3.pptx25.0 Nuclear Physics Sem 3.pptx
25.0 Nuclear Physics Sem 3.pptxssuser955fb81
 
Radiopharmaceuticals
RadiopharmaceuticalsRadiopharmaceuticals
RadiopharmaceuticalsHemantAlhat1
 
Radiopharmaceuticals
RadiopharmaceuticalsRadiopharmaceuticals
RadiopharmaceuticalsHemantAlhat1
 
Physics in Nuclear Medicine
Physics in Nuclear MedicinePhysics in Nuclear Medicine
Physics in Nuclear Medicine@Saudi_nmc
 
Physics in Nuclear Medicine
Physics in Nuclear MedicinePhysics in Nuclear Medicine
Physics in Nuclear Medicine@Saudi_nmc
 
02. Radiation and Radiation Protection 2324.pdf
02. Radiation and Radiation Protection 2324.pdf02. Radiation and Radiation Protection 2324.pdf
02. Radiation and Radiation Protection 2324.pdfMassimoZucchetti4
 
02. Radiation and Radiation Protection 2324.pdf
02. Radiation and Radiation Protection 2324.pdf02. Radiation and Radiation Protection 2324.pdf
02. Radiation and Radiation Protection 2324.pdfMassimoZucchetti4
 
An Overview about Radiation Protection_2024
An Overview about Radiation Protection_2024An Overview about Radiation Protection_2024
An Overview about Radiation Protection_2024RozilawatiAhmad2
 
An Overview about Radiation Protection_2024
An Overview about Radiation Protection_2024An Overview about Radiation Protection_2024
An Overview about Radiation Protection_2024RozilawatiAhmad2
 
Proton beam therapy
Proton beam therapyProton beam therapy
Proton beam therapyAmin Amin
 
Proton beam therapy
Proton beam therapyProton beam therapy
Proton beam therapyAmin Amin
 

Similar to Radiopharmaciutics...................................... (20)

Nuclear Medicine.pdf
Nuclear Medicine.pdfNuclear Medicine.pdf
Nuclear Medicine.pdf
 
Nuclear Medicine.pdf
Nuclear Medicine.pdfNuclear Medicine.pdf
Nuclear Medicine.pdf
 
COMPARISION BETWEEN 1 H & 13 C NMR
COMPARISION  BETWEEN  1 H  & 13 C NMRCOMPARISION  BETWEEN  1 H  & 13 C NMR
COMPARISION BETWEEN 1 H & 13 C NMR
 
COMPARISION BETWEEN 1 H & 13 C NMR
COMPARISION  BETWEEN  1 H  & 13 C NMRCOMPARISION  BETWEEN  1 H  & 13 C NMR
COMPARISION BETWEEN 1 H & 13 C NMR
 
NMR Spectroscopy
NMR SpectroscopyNMR Spectroscopy
NMR Spectroscopy
 
NMR Spectroscopy
NMR SpectroscopyNMR Spectroscopy
NMR Spectroscopy
 
تشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسي
تشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسيتشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسي
تشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسي
 
تشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسي
تشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسيتشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسي
تشخيص المركبات العضوية بواسطة الرنين النووي المغناطيسي
 
25.0 Nuclear Physics Sem 3.pptx
25.0 Nuclear Physics Sem 3.pptx25.0 Nuclear Physics Sem 3.pptx
25.0 Nuclear Physics Sem 3.pptx
 
25.0 Nuclear Physics Sem 3.pptx
25.0 Nuclear Physics Sem 3.pptx25.0 Nuclear Physics Sem 3.pptx
25.0 Nuclear Physics Sem 3.pptx
 
Radiopharmaceuticals
RadiopharmaceuticalsRadiopharmaceuticals
Radiopharmaceuticals
 
Radiopharmaceuticals
RadiopharmaceuticalsRadiopharmaceuticals
Radiopharmaceuticals
 
Physics in Nuclear Medicine
Physics in Nuclear MedicinePhysics in Nuclear Medicine
Physics in Nuclear Medicine
 
Physics in Nuclear Medicine
Physics in Nuclear MedicinePhysics in Nuclear Medicine
Physics in Nuclear Medicine
 
02. Radiation and Radiation Protection 2324.pdf
02. Radiation and Radiation Protection 2324.pdf02. Radiation and Radiation Protection 2324.pdf
02. Radiation and Radiation Protection 2324.pdf
 
02. Radiation and Radiation Protection 2324.pdf
02. Radiation and Radiation Protection 2324.pdf02. Radiation and Radiation Protection 2324.pdf
02. Radiation and Radiation Protection 2324.pdf
 
An Overview about Radiation Protection_2024
An Overview about Radiation Protection_2024An Overview about Radiation Protection_2024
An Overview about Radiation Protection_2024
 
An Overview about Radiation Protection_2024
An Overview about Radiation Protection_2024An Overview about Radiation Protection_2024
An Overview about Radiation Protection_2024
 
Proton beam therapy
Proton beam therapyProton beam therapy
Proton beam therapy
 
Proton beam therapy
Proton beam therapyProton beam therapy
Proton beam therapy
 

Recently uploaded

I’ll See Y’All Motherfuckers In Game 7 Shirt
I’ll See Y’All Motherfuckers In Game 7 ShirtI’ll See Y’All Motherfuckers In Game 7 Shirt
I’ll See Y’All Motherfuckers In Game 7 Shirtrahman018755
 
Bug Bounty Blueprint : A Beginner's Guide
Bug Bounty Blueprint : A Beginner's GuideBug Bounty Blueprint : A Beginner's Guide
Bug Bounty Blueprint : A Beginner's GuideVarun Mithran
 
iThome_CYBERSEC2024_Drive_Into_the_DarkWeb
iThome_CYBERSEC2024_Drive_Into_the_DarkWebiThome_CYBERSEC2024_Drive_Into_the_DarkWeb
iThome_CYBERSEC2024_Drive_Into_the_DarkWebJie Liau
 
The Use of AI in Indonesia Election 2024: A Case Study
The Use of AI in Indonesia Election 2024: A Case StudyThe Use of AI in Indonesia Election 2024: A Case Study
The Use of AI in Indonesia Election 2024: A Case StudyDamar Juniarto
 
TORTOGEL TELAH MENJADI SALAH SATU PLATFORM PERMAINAN PALING FAVORIT.
TORTOGEL TELAH MENJADI SALAH SATU PLATFORM PERMAINAN PALING FAVORIT.TORTOGEL TELAH MENJADI SALAH SATU PLATFORM PERMAINAN PALING FAVORIT.
TORTOGEL TELAH MENJADI SALAH SATU PLATFORM PERMAINAN PALING FAVORIT.Tortogel
 
Development Lifecycle.pptx for the secure development of apps
Development Lifecycle.pptx for the secure development of appsDevelopment Lifecycle.pptx for the secure development of apps
Development Lifecycle.pptx for the secure development of appscristianmanaila2
 
Topology of the Network class 8 .ppt pdf
Topology of the Network class 8 .ppt pdfTopology of the Network class 8 .ppt pdf
Topology of the Network class 8 .ppt pdfAnushkaTripathi61
 
Thank You Luv I’ll Never Walk Alone Again T shirts
Thank You Luv I’ll Never Walk Alone Again T shirtsThank You Luv I’ll Never Walk Alone Again T shirts
Thank You Luv I’ll Never Walk Alone Again T shirtsrahman018755
 
Premier Mobile App Development Agency in USA.pdf
Premier Mobile App Development Agency in USA.pdfPremier Mobile App Development Agency in USA.pdf
Premier Mobile App Development Agency in USA.pdfappinfoedgeca
 
Production 2024 sunderland culture final - Copy.pptx
Production 2024 sunderland culture final - Copy.pptxProduction 2024 sunderland culture final - Copy.pptx
Production 2024 sunderland culture final - Copy.pptxChloeMeadows1
 
Cyber Security Services Unveiled: Strategies to Secure Your Digital Presence
Cyber Security Services Unveiled: Strategies to Secure Your Digital PresenceCyber Security Services Unveiled: Strategies to Secure Your Digital Presence
Cyber Security Services Unveiled: Strategies to Secure Your Digital PresencePC Doctors NET
 
How Do I Begin the Linksys Velop Setup Process?
How Do I Begin the Linksys Velop Setup Process?How Do I Begin the Linksys Velop Setup Process?
How Do I Begin the Linksys Velop Setup Process?Linksys Velop Login
 
Pvtaan Social media marketing proposal.pdf
Pvtaan Social media marketing proposal.pdfPvtaan Social media marketing proposal.pdf
Pvtaan Social media marketing proposal.pdfPvtaan
 
audience research (emma) 1.pptxkkkkkkkkkkkkkkkkk
audience research (emma) 1.pptxkkkkkkkkkkkkkkkkkaudience research (emma) 1.pptxkkkkkkkkkkkkkkkkk
audience research (emma) 1.pptxkkkkkkkkkkkkkkkkklolsDocherty
 
Statistical Analysis of DNS Latencies.pdf
Statistical Analysis of DNS Latencies.pdfStatistical Analysis of DNS Latencies.pdf
Statistical Analysis of DNS Latencies.pdfOndejSur
 
Reggie miller choke t shirtsReggie miller choke t shirts
Reggie miller choke t shirtsReggie miller choke t shirtsReggie miller choke t shirtsReggie miller choke t shirts
Reggie miller choke t shirtsReggie miller choke t shirtsrahman018755
 

Recently uploaded (16)

I’ll See Y’All Motherfuckers In Game 7 Shirt
I’ll See Y’All Motherfuckers In Game 7 ShirtI’ll See Y’All Motherfuckers In Game 7 Shirt
I’ll See Y’All Motherfuckers In Game 7 Shirt
 
Bug Bounty Blueprint : A Beginner's Guide
Bug Bounty Blueprint : A Beginner's GuideBug Bounty Blueprint : A Beginner's Guide
Bug Bounty Blueprint : A Beginner's Guide
 
iThome_CYBERSEC2024_Drive_Into_the_DarkWeb
iThome_CYBERSEC2024_Drive_Into_the_DarkWebiThome_CYBERSEC2024_Drive_Into_the_DarkWeb
iThome_CYBERSEC2024_Drive_Into_the_DarkWeb
 
The Use of AI in Indonesia Election 2024: A Case Study
The Use of AI in Indonesia Election 2024: A Case StudyThe Use of AI in Indonesia Election 2024: A Case Study
The Use of AI in Indonesia Election 2024: A Case Study
 
TORTOGEL TELAH MENJADI SALAH SATU PLATFORM PERMAINAN PALING FAVORIT.
TORTOGEL TELAH MENJADI SALAH SATU PLATFORM PERMAINAN PALING FAVORIT.TORTOGEL TELAH MENJADI SALAH SATU PLATFORM PERMAINAN PALING FAVORIT.
TORTOGEL TELAH MENJADI SALAH SATU PLATFORM PERMAINAN PALING FAVORIT.
 
Development Lifecycle.pptx for the secure development of apps
Development Lifecycle.pptx for the secure development of appsDevelopment Lifecycle.pptx for the secure development of apps
Development Lifecycle.pptx for the secure development of apps
 
Topology of the Network class 8 .ppt pdf
Topology of the Network class 8 .ppt pdfTopology of the Network class 8 .ppt pdf
Topology of the Network class 8 .ppt pdf
 
Thank You Luv I’ll Never Walk Alone Again T shirts
Thank You Luv I’ll Never Walk Alone Again T shirtsThank You Luv I’ll Never Walk Alone Again T shirts
Thank You Luv I’ll Never Walk Alone Again T shirts
 
Premier Mobile App Development Agency in USA.pdf
Premier Mobile App Development Agency in USA.pdfPremier Mobile App Development Agency in USA.pdf
Premier Mobile App Development Agency in USA.pdf
 
Production 2024 sunderland culture final - Copy.pptx
Production 2024 sunderland culture final - Copy.pptxProduction 2024 sunderland culture final - Copy.pptx
Production 2024 sunderland culture final - Copy.pptx
 
Cyber Security Services Unveiled: Strategies to Secure Your Digital Presence
Cyber Security Services Unveiled: Strategies to Secure Your Digital PresenceCyber Security Services Unveiled: Strategies to Secure Your Digital Presence
Cyber Security Services Unveiled: Strategies to Secure Your Digital Presence
 
How Do I Begin the Linksys Velop Setup Process?
How Do I Begin the Linksys Velop Setup Process?How Do I Begin the Linksys Velop Setup Process?
How Do I Begin the Linksys Velop Setup Process?
 
Pvtaan Social media marketing proposal.pdf
Pvtaan Social media marketing proposal.pdfPvtaan Social media marketing proposal.pdf
Pvtaan Social media marketing proposal.pdf
 
audience research (emma) 1.pptxkkkkkkkkkkkkkkkkk
audience research (emma) 1.pptxkkkkkkkkkkkkkkkkkaudience research (emma) 1.pptxkkkkkkkkkkkkkkkkk
audience research (emma) 1.pptxkkkkkkkkkkkkkkkkk
 
Statistical Analysis of DNS Latencies.pdf
Statistical Analysis of DNS Latencies.pdfStatistical Analysis of DNS Latencies.pdf
Statistical Analysis of DNS Latencies.pdf
 
Reggie miller choke t shirtsReggie miller choke t shirts
Reggie miller choke t shirtsReggie miller choke t shirtsReggie miller choke t shirtsReggie miller choke t shirts
Reggie miller choke t shirtsReggie miller choke t shirts
 

Radiopharmaciutics......................................

  • 1. Debre Berhan University Health Science College Pharmacy Department Pharmaceutics Unit Aychew M. (B.Pharm, MSc Candidate) 2014E.C Radiopharmaceuticals Integrated Physical Pharmacy and Pharmaceutics II (Phar 3121)
  • 2. Chapter objective ➢After completion of this chapter, you will be able to: ✓Compare and contrast the three principal types of radioactive decay ✓Discuss the use of radiopharmaceuticals in diagnostics and therapeutics. ✓Discuss preparation of radiopharmaceuticals By: Aychew M. IPP II(Phar3121) 2014EC 2
  • 3. Chapter objective… ✓Enumerate the ideal properties of radiopharmaceuticals ✓Describe storage and disposal of radiopharmaceuticals By: Aychew M. IPP II(Phar3121) 2014EC 3
  • 4. Introduction ➢Radiopharmaceutical is a radioactive pharmaceutical agent that is used for diagnostic or therapeutic procedures ✓ The diagnostic side is well established, while the therapeutic side of nuclear medicine is evolving ➢Radiation is an inherent characteristic of all radiopharmaceuticals, and patients always receive an unavoidable radiation dose By: Aychew M. IPP II(Phar3121) 2014EC 4
  • 5. Introduction… ➢A radiopharmaceutical can be ✓As simple as a radioactive element such as 133Xe, ✓A simple salt such as 131I-NaI, or ✓A labeled compound such as 131I-iodinated proteins and 99mTc-labeled compounds. (Technetium-99m) By: Aychew M. IPP II(Phar3121) 2014EC 5
  • 6. Introduction… ➢A radiopharmaceutical has two components ✓ Radionuclide ❖ Provides the desired radiation characteristics ✓ Pharmaceutical ❖ A chemical compound with structural or chemical properties that determine the in vivo distribution and physiological behavior of the radiopharmaceutical ✓ Other additives By: Aychew M. IPP II(Phar3121) 2014EC 6
  • 7. Introduction… ➢A suitable radionuclide is tagged onto the chosen pharmaceutical such that after administration of the radiopharmaceutical, radiations emitted from it are detected by a radiation detector ✓Thus, the morphologic structure or the physiologic function of the organ can be assessed By: Aychew M. IPP II(Phar3121) 2014EC 7
  • 8. Introduction… ➢The usefulness of a radiopharmaceutical is dictated by the characteristics of these two components which are radionuclide and pharmaceutical By: Aychew M. IPP II(Phar3121) 2014EC 8
  • 9. Radionuclide ➢ Radionuclides are unstable nuclei that are stabilized upon radioactive decay. ➢Approximately 3000 nuclides have been discovered so far; most of these are unstable, but only about 30 of these are routinely used in nuclear medicine. By: Aychew M. IPP II(Phar3121) 2014EC 9
  • 10. Radionuclide… ➢The nucleus of an atom is composed of protons and neutrons, collectively called nucleons. ✓The number of protons in a nucleus is called the atomic number of the atom, denoted by Z. ✓The number of neutrons is denoted by N. ➢The total number of nucleons in a nucleus is referred to as the mass number, denoted by A. Thus, A is equal to Z + N. By: Aychew M. IPP II(Phar3121) 2014EC 10
  • 11. Radionuclide… ➢The ratio N/Z is an approximate index of the stability of a nuclide. ✓This ratio equals 1 in the stable nuclei with a low atomic number, such as 12 6C, 16 8O, and 14 7N ✓The ratio increases with the increasing atomic number of the nucleus. ✓For example, it is 1.40 for 127 53I and 1.54 for 208 82Pb. By: Aychew M. IPP II(Phar3121) 2014EC 11
  • 12. Radionuclide… ➢Nuclei with N/Z different from the stable nuclei are unstable and decay by emitting different types of ionizing radiation: ✓Alpha (α) ✓Beta minus (β-) ✓Positron (β+) and ✓Gamma (γ) radiation. By: Aychew M. IPP II(Phar3121) 2014EC 12
  • 13. Decay of Radionuclide ➢If the daughter nucleus is stable, this spontaneous transformation ends ✓If the daughter is unstable, the process continues until a stable nuclide is reached ➢Diagnostic radiopharmaceuticals should decay by gamma emission or positron emission By: Aychew M. IPP II(Phar3121) 2014EC 13
  • 14. Decay of Radionuclide… ➢Therapeutic radiopharmaceuticals should decay by particulate decay (alpha or beta minus) since the intended effect is radiation damage to specific cells By: Aychew M. IPP II(Phar3121) 2014EC 14
  • 15. Decay of Radionuclide… Alpha () decay ➢Alpha () decay is characterized by the emission of an alpha particle from the nucleus. ➢ particle is a helium ion containing two protons and two neutrons bound together in the nucleus. 2 4 2 4 A 2 Z A Z He Y X + − − + → By: Aychew M. IPP II(Phar3121) 2014EC 15
  • 16. Decay of Radionuclide… ➢The  particles are mono-energetic, and their range in matter is very short (on the order of 10-6 cm) due to their mass, thus leaving much of its energy on a very small area (only a few cell diameters) ➢Used only for therapeutic purposes ➢Their clinical use is very limited, and they are mainly used for research purposes By: Aychew M. IPP II(Phar3121) 2014EC 16
  • 17. Beta-Minus (Negatron) Decay ➢Beta-minus (-) decay characteristically occurs with radionuclides that have an excess number of neutrons (‘‘neutron rich’’) compared with the number of protons i.e., has a higher N/Z ratio compared to the stable nucleus In - decay, a neutron (n) decays into a proton (p) and a - particle By: Aychew M. IPP II(Phar3121) 2014EC 17
  • 18. Beta-Minus (Negatron) Decay… ➢After - decay, the atomic number of the daughter nuclide is one more than that of the parent nuclide; however, the mass number remains the same for both nuclides ✓ An antineutrino ( ) is an entity almost without mass and charge and is primarily needed to conserve energy in the decay  β Y X - A 1 Z A Z + + → +  By: Aychew M. IPP II(Phar3121) 2014EC 18
  • 19. Beta-Minus (Negatron) Decay… ➢The - particle is emitted with variable energy from zero up to the decay energy. ✓The decay or transition energy is the difference in energy between the parent and daughter nuclides. ✓An antineutrino carries away the difference between the - particle energy and the decay energy. By: Aychew M. IPP II(Phar3121) 2014EC 19
  • 20. Decay of Radionuclide… By: Aychew M. IPP II(Phar3121) 2014EC 20
  • 21. Beta-Minus (Negatron) Decay… ➢Beta emitters represent different energy levels, and have different range in matter (40-100μm) depending on their energy. ➢Beta particles are not as destructive as alpha particles ✓However, Beta emitting radionuclides are used in radiopharmaceuticals mainly for therapeutic purposes By: Aychew M. IPP II(Phar3121) 2014EC 21
  • 22. Decay of Radionuclide… Positron or β+ Decay ➢Nuclei that are ‘‘neutron deficient’’ or ‘‘proton rich’’ (i.e., have an N/Z ratio less than that of the stable nuclei) can decay by β+-particle emission accompanied by the emission of a neutrino (V), which is an opposite entity of the antineutrino. By: Aychew M. IPP II(Phar3121) 2014EC 22
  • 23. Positron or β+ Decay… ➢In β+ decay, a proton transforms into a neutron by emitting a β+ -particle ✓The daughter nuclide has an atomic number that is 1 less than that of the parent ➢Since a β+ particle can be emitted with energy between zero and decay energy, the neutrino carries away the difference between decay energy and β+ energy. 23
  • 24. Positron or β+ Decay…  β Y X A 1 - Z A Z + + → + By: Aychew M. IPP II(Phar3121) 2014EC 24
  • 25. Decay of Radionuclide…. Gamma radiation ➢A nucleus can remain in several excited energy states above the ground state ✓All these excited states are referred to as isomeric states and decay to the ground state ✓The decay of an upper excited state to a lower excited state is called the isomeric transition By: Aychew M. IPP II(Phar3121) 2014EC 25
  • 26. Gamma radiation… ➢In isomeric transition, the energy difference between the energy states may appear as gamma (γ) rays. ✓Gamma radiation is characterized as electromagnetic radiation ✓When used in diagnostic radiopharmaceuticals, gamma rays are powerful enough to be detected outside the body of the patient By: Aychew M. IPP II(Phar3121) 2014EC 26
  • 27. Activity of Radionuclide ➢The activity of radioactive material may be calculated by a decay equation that allows the clinician to predict the activity at any time ➢The specific decay equation: Where: Ao is the initial activity, ✓ Ae is the specific activity at time t, ✓ λ is the decay constant calculated as ln2/half life, and t is time By: Aychew M. IPP II(Phar3121) 2014EC 27
  • 28. Activity of radioactive… ➢The fundamental unit of radioactivity is the curie (Ci) ✓Defined as 3.700 × 1010 nuclear transformations per second or disintegrations per second (dps) ➢ Another unit of activity is the becquerel (Bq). ✓The becquerel is equivalent to 2.703 × 10−11 Ci By: Aychew M. IPP II(Phar3121) 2014EC 28
  • 29. Activity of radioactive… Example ➢If a doctor is prescribed a 15 mCi dose of 99mTc to the patient how much is it in Bq By: Aychew M. IPP II(Phar3121) 2014EC 29
  • 30. Activity of radioactive… ➢The amount of radiation absorbed by body tissue in which a radioactive substance resides is called the radiation dose. ✓The Gray (Gy) is the international unit of absorbed dose, equal to 1 joule of energy absorbed by 1 kg of tissue ➢Radiopharmaceutical doses are dispensed to patients in units of activity, typically mCi or μCi. By: Aychew M. IPP II(Phar3121) 2014EC 30
  • 31. Production of Radionuclide ➢All radionuclides commonly administered to patients in nuclear medicine are artificially produced ➢Most are produced by: ✓Cyclotrons ✓Nuclear reactors ✓Radionuclide generators By: Aychew M. IPP II(Phar3121) 2014EC 31
  • 32. Production of Radionuclide… Cyclotron-Produced Radionuclides ➢Cyclotrons produce radionuclides by bombarding stable nuclei (target elements) with high-energy charged particles such as protons, deutérons, and α particules ➢When targets of stable elements are irradiated nuclear reactions take place. By: Aychew M. IPP II(Phar3121) 2014EC 32
  • 33. Cyclotron-Produced Radionuclides… ➢In a nuclear reaction, the incident particle may leave the nucleus after the interaction, leaving some of its energy in it, or it may be completely absorbed by the nucleus, depending on the energy of the incident particle. By: Aychew M. IPP II(Phar3121) 2014EC 33
  • 34. Cyclotron-Produced Radionuclides… ➢Depending on the energy deposited by the incident particle, a number of nucleons are emitted randomly from the irradiated target nucleus, leading to the formation of different nuclides. By: Aychew M. IPP II(Phar3121) 2014EC 34
  • 35. Cyclotron-Produced Radionuclides… ➢Cyclotron-produced radionuclides are usually neutron deficient and therefore decay by β+ emission Example ➢ Iodine-123 can be produced by several nuclear reactions in cyclotron such as ✓ 121Sb(α, 2n) 123I 123Te (p, n) 123I ✓ 122Te (d, n)123I 124Te(p, 2n) 123I. By: Aychew M. IPP II(Phar3121) 2014EC 35
  • 36. Cyclotron-Produced Radionuclides… ➢Gallium-67 can also be produced by several nuclear reactions ✓66Zn(d, n)67Ga, ✓68Zn(p, 2n) 67Ga, and ✓64Zn(α, Þ) 67Ga. By: Aychew M. IPP II(Phar3121) 2014EC 36
  • 37. Production of Radionuclide… Reactor-Produced Radionuclides ➢A nuclear reactor is constructed with fuel rods made of fissile materials such as enriched 235U & 239Pu ➢When a target element is inserted in the reactor core, a thermal neutron will interact with the target nucleus to produce various radionuclides. By: Aychew M. IPP II(Phar3121) 2014EC 37
  • 38. Reactor-Produced Radionuclides… ➢In the reactor, two types of interaction with neutrons are of considerable importance in the production of various useful radionuclides: ✓Fission of heavy elements ✓Neutron capture reaction By: Aychew M. IPP II(Phar3121) 2014EC 38
  • 39. Reactor-Produced Radionuclides… Fission Reaction ➢ Fission is defined as the breakup of a heavy nucleus into two fragments of approximately equal mass, accompanied by the emission of two to three neutrons with mean energies of about 1.5 MeV. By: Aychew M. IPP II(Phar3121) 2014EC 39
  • 40. Reactor-Produced Radionuclides… ➢When a target of heavy elements is inserted in the reactor core, heavy nuclei absorb thermal neutrons and undergo fission. ➢Fissionable heavy elements are 235U, 239Pu, 237Np, 232Th. By: Aychew M. IPP II(Phar3121) 2014EC 40
  • 41. Reactor-Produced Radionuclides… ➢Many clinically useful radionuclides such as 131I, 99Mo, 133Xe, and 137Cs are produced by fission of 235U. By: Aychew M. IPP II(Phar3121) 2014EC 41
  • 42. Reactor-Produced Radionuclides… ➢Nuclides produced by fission may range in atomic number from about 28 to nearly 65 ➢These isotopes of different elements are separated by appropriate chemical procedures that involve: ✓ Precipitation ✓ Solvent extraction ✓ Ion exchange chromatography ➢The fission products are usually neutron-rich and decay by - particle emission By: Aychew M. IPP II(Phar3121) 2014EC 42
  • 43. Reactor-Produced Radionuclides… Neutron Capture Reaction ➢The target nucleus captures one thermal neutron and emits gamma (γ) rays to produce an isotope of the same element ✓The target and the product nuclei belong to the same element By: Aychew M. IPP II(Phar3121) 2014EC 43
  • 44. Neutron Capture Reaction… ➢Some examples of neutron capture reactions are ✓98Mo(n, γ ) 99Mo ✓196Hg(n, γ) 197Hg ✓50Cr (n, γ) 51Cr By: Aychew M. IPP II(Phar3121) 2014EC 44
  • 45. Production of Radionuclide… Radionuclide Generators ➢Since cyclotrons and reactors are expensive, these facilities are limited and supply radionuclide to remote facilities that do not possess such equipment. By: Aychew M. IPP II(Phar3121) 2014EC 45
  • 46. Radionuclide Generators… ➢Very short-lived radionuclides are available only in the institutions that have the cyclotron or reactor facilities; they cannot be supplied to remote institutions or hospitals because they decay rapidly. By: Aychew M. IPP II(Phar3121) 2014EC 46
  • 47. Radionuclide Generators… ➢For remote facilities, however, there is a secondary source of radionuclides, particularly short-lived ones, which is called a radionuclide generator By: Aychew M. IPP II(Phar3121) 2014EC 47
  • 48. Radionuclide Generators… Principles of a Generator ➢A generator is constructed on the principle of the decay-growth relationship between a long-lived parent radionuclide and its short-lived daughter radionuclide. ➢In a generator, basically a long-lived parent nuclide is allowed to decay to its short-lived daughter nuclide, and the latter is then chemically separated. By: Aychew M. IPP II(Phar3121) 2014EC 48
  • 49. Radionuclide Generators… ➢The importance of radionuclide generators lies in the fact that they are easily transportable and serve as sources of short-lived radionuclides in institutions far from the site of a cyclotron or reactor facility. By: Aychew M. IPP II(Phar3121) 2014EC 49
  • 50. Radionuclide Generators… ➢An ideal radionuclide generator should be ✓ Simple ✓ Convenient ✓ Rapid to use ✓ Give a high yield of the daughter nuclide repeatedly and reproducibly ✓ Properly shielded to minimize radiation exposure ✓ Strong and compact for shipping By: Aychew M. IPP II(Phar3121) 2014EC 50
  • 51. Radionuclide Generators… ➢Generator systems important in nuclear medicine: ✓99Mo – 99mTc ✓113Sn – 113mIn ✓82Sr – 82Rb ✓68Ge – 68Ga By: Aychew M. IPP II(Phar3121) 2014EC 51
  • 52. 99Mo–99mTc Generator system ➢The parent radionuclide 99Mo has a half-life of 66 hr and decays to the metastable state 99mTc ➢The daughter radionuclide 99mTc has a half-life of 6 hr and decays to 99Tc (stable one) by the isomeric transition of 140 keV (emit gamma-ray) ✓Nearly ideal for the current generation of imaging devices in nuclear medicine. By: Aychew M. IPP II(Phar3121) 2014EC 52
  • 53. Ideal properties of radiopharmaceutical 1. Easy Availability ➢ Should be inexpensive, and readily available in any nuclear medicine facility. 2. Short Effective Half-Life ➢ A radionuclide decays with a definite half-life, which is called the physical half-life (the time during which an initial activity of a radionuclide is reduced to one half- Tp) and By: Aychew M. IPP II(Phar3121) 2014EC 53
  • 54. Ideal properties of radiopharmaceutical… ➢ It disappears from the body with a certain biologic half-life (the time needed for half of the radiopharmaceutical to disappear from the biologic system - Tb). ➢ In any biologic system, the loss of a radiopharmaceutical is due to both the physical decay of the radionuclide and the biologic elimination of the radiopharmaceutical By: Aychew M. IPP II(Phar3121) 2014EC 54
  • 55. Ideal properties… ✓ Therefore the effective half-life can be given as: ✓ Radiopharmaceuticals should have a relatively short effective half-life, which should not be longer than the time necessary to complete the study in question. By: Aychew M. IPP II(Phar3121) 2014EC 55
  • 56. Ideal properties… Example ➢The physical half-life of 111In is 67 hr and the biologic half-life of 111In-DTPA used for measurement of the glomerular filtration rate is 1.5 hr. What is the effective half-life of 111In- DTPA? By: Aychew M. IPP II(Phar3121) 2014EC 56
  • 57. 3. Appropriate radiation oParticle Emission ➢Radionuclides decaying by α- and β-particle emission should not be used as the label in diagnostic radiopharmaceuticals. ➢These particles cause more radiation damage to the tissue than do γ rays ➢α and β emitters are useful for therapy, because of the effective radiation damage to abnormal cells. By: Aychew M. IPP II(Phar3121) 2014EC 57
  • 58. Ideal properties… oGamma (γ)emitter For diagnostic studies the radionuclide must emit a γ radiation with an energy preferably between 30 and 300 keV. Below 30 keV, γ rays are absorbed by tissue and are not detected by the detector By: Aychew M. IPP II(Phar3121) 2014EC 58
  • 59. Gamma (γ)emitter … Above 300 keV, the gamma ray penetrate the detector of the imaging device without being stopped and hence recorded. By: Aychew M. IPP II(Phar3121) 2014EC 59
  • 60. By: Aychew M. IPP II(Phar3121) 2014EC 60
  • 61. Ideal properties… 4. High Target-to-Non-target Activity Ratio For diagnostic study, it is desirable that the radiopharmaceutical be localized preferentially in the organ under study since the activity from non-target areas can obscure the structural details of the picture of the target organ. By: Aychew M. IPP II(Phar3121) 2014EC 61
  • 62. High Target-to-Non-target Activity Ratio… ➢A low target-to-non-target ratio may result in inadequate treatment of the primary disease and delivery of a potentially lethal radiation dose to bone marrow or other radiosensitive tissues By: Aychew M. IPP II(Phar3121) 2014EC 62
  • 63. Ideal properties… 5. Low dose rate to both patient and personnel 6. Non-toxicity of radiopharmaceuticals They must be non-toxic in nature, sterile and pyrogenic-free. 7. Chemical Reactivity Should react with variety of substrates for radiolabeling reactions By: Aychew M. IPP II(Phar3121) 2014EC 63
  • 64. Ideal properties… 8. Chemical stability during use Must be stable both pre- and post-reconstitution 9. Ease of preparation and appropriate quality control Several steps and a complex variety of equipment should not be required. By: Aychew M. IPP II(Phar3121) 2014EC 64
  • 65. Ideal properties… Quality control procedures should be available to check each batch of the radiopharmaceutical reconstituted in the working laboratory. By: Aychew M. IPP II(Phar3121) 2014EC 65
  • 66. Storage of radiopharmaceuticals Should be properly stored so that they are not degraded by light or temperature. For example 99mTc-labeled macro aggregated albumin should be stored at 2 to 4oC to prevent any bacterial growth and denaturation of proteins, 99mTc-sulfur colloid can be stored at room temperature without any adverse effect. By: Aychew M. IPP II(Phar3121) 2014EC 66
  • 67. Storage… Since radiation exposure is a serious problem in the nuclear pharmacy, the vials or syringes containing radiopharmaceuticals must be stored in a shielded area. Various high atomic number materials that absorb radiation can be used to provide radiation protection. By: Aychew M. IPP II(Phar3121) 2014EC 67
  • 68. Storage… Since the ranges of α and β particles are short in the matter, the containers themselves act as shields for these radiations. γ radiations are highly penetrating, and therefore highly absorbing material must be used for shielding of γ -emitting sources. ➢For economic reasons, lead is most commonly used for this purpose. By: Aychew M. IPP II(Phar3121) 2014EC 68
  • 69. Lead barrier shield, behind which all formulations and manipulations of radioactive materials are carried out. By: Aychew M. IPP II(Phar3121) 2014EC 69
  • 70. Storage… Lead-shield syringe holder for transporting the syringes containing radioactive material. By: Aychew M. IPP II(Phar3121) 2014EC 70
  • 71. Radioactive Waste Disposal Radioactive waste generated in nuclear medicine or pharmacy (e.g., syringes, needles, vials containing residual activities, liquid waste, gas, and contaminated papers, tissues, and liners) is disposed of by the following methods: Decay-in-storage Release into a sewerage system By: Aychew M. IPP II(Phar3121) 2014EC 71
  • 72. Radioactive Waste Disposal… Transfer to an authorized recipient Other disposal methods (e.g., incineration and atmospheric release of radioactive gases). By: Aychew M. IPP II(Phar3121) 2014EC 72
  • 73. Radioactive Waste Disposal… Decay-in-storage Radionuclides with half-lives less than 120 days usually are disposed of by this method. By: Aychew M. IPP II(Phar3121) 2014EC 73
  • 74. Decay-in-storage… The waste is allowed to decay for a period of time and then surveyed. If the radioactivity of the waste cannot be distinguished from the background, it can be disposed of in the normal trash after the removal of all radiation labels. By: Aychew M. IPP II(Phar3121) 2014EC 74
  • 75. Decay-in-storage… Most appropriate for short-lived radionuclides such as 99mTc, 123I, 201Tl, 111In, and 67Ga, By: Aychew M. IPP II(Phar3121) 2014EC 75
  • 76. Radioactive Waste Disposal… Release into a Sewerage System Radioactive waste disposal into a sewerage system is permitted provided the radioactive material is soluble (or dispersible biological material) in water. Disposal depends on the flow rate of water but is limited to 1 Ci (37 GBq) of 14C, 5 Ci (185 GBq) of 3H, and 1 Ci (37 GBq) for all other radionuclides annually. By: Aychew M. IPP II(Phar3121) 2014EC 76
  • 77. Radioactive Waste Disposal… Transfer to an Authorized Recipient ➢A transfer to an authorized recipient method is adopted for long-lived radionuclides ➢Usually involves the transfer of radioactive waste to authorized commercial firms that bury or incinerate it at approved sites or facilities. By: Aychew M. IPP II(Phar3121) 2014EC 77
  • 78. By: Aychew M. IPP II(Phar3121) 2014EC 78
  • 79. By: Aychew M. IPP II(Phar3121) 2014EC 79